Human Combinatorial Antibody Libraries for High-Specificity Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating antibody therapeutics are limited in creating antibodies with improved specificity, affinity, bioavailability, and stability, as existing techniques for generating antibody libraries are restrictive and do not fully leverage the diversity of human germline segments.
Innovation Solution
The development of human combinatorial antibody libraries by rearranging human germline segments to create diverse antibodies with variable light and heavy chains, encoded by nucleic acid molecules containing Vκ, Vλ, Jκ, and Jλ segments, which are linked in-frame to form functional and productive antibodies, allowing for extensive screening and modification to enhance antigen binding properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If existing techniques for generating antibody libraries are used, then the process is relatively simple, but the diversity and functionality of generated antibodies are limited
Solution Approach 1:
The patent divides the antibody generation process into separate modules: germline segment selection, combinatorial rearrangement, and library construction. By segmenting the heavy and light chain gene regions into distinct selectable components, the system achieves comprehensive antibody diversity while maintaining manageable complexity through systematic assembly of predefined segments.
Solution Approach 2:
The patent implements nested combinatorial libraries where multiple levels of diversity are arranged hierarchically. The structure contains outer and inner combinatorial layers that can be screened sequentially, allowing the system to manage vast antibody diversity through organized nesting of gene segment combinations rather than random generation.
2Manufacturing precision
If human germline segments are rearranged to create diverse antibodies, then antibody specificity and affinity are improved, but the manufacturing process becomes more complex
Solution Approach 1:
The patent performs preliminary organization of human germline segments into curated collections with known properties before library construction. By pre-characterizing and categorizing V, D, and J segments, the system establishes a ready-to-use foundation that simplifies subsequent library assembly while ensuring high antibody specificity through selection from pre-validated germline sequences.
Solution Approach 2:
The patent systematically varies key parameters including germline segment selection, combinatorial arrangement patterns, and library composition ratios to optimize both antibody specificity and manufacturing feasibility. By adjusting these parameters, the system balances the complexity of generating diverse, high-specificity antibodies with the practical constraints of library construction and screening capacity.
3Reliability
If combinatorial antibody libraries are generated with extensive diversity, then the probability of finding high-affinity antibodies increases, but the screening time and resources increase
Solution Approach 1:
The patent implements nested combinatorial libraries where multiple levels of diversity are arranged hierarchically. The structure contains outer and inner combinatorial layers that can be screened sequentially, allowing the system to manage vast antibody diversity through organized nesting of gene segment combinations rather than random generation.
Solution Approach 2:
The patent generates libraries with diversity that exceeds immediate screening capacity, intentionally creating more variants than can be screened at once. This excessive action ensures comprehensive coverage of the antibody space, with the understanding that not all members will be screened simultaneously, but the full diversity will be available for iterative screening rounds.
Data Source
AI summary
Methods for making a combinatorial antibody library from human germline segments are provided. Also provided are libraries of nucleic acid molecules compiled from germline segments encoding VL chains and libraries of nucleic acid molecules encoding VH chains, and resulting antibody libraries. The libraries are provided as addressable libraries. Methods for screening antibody libraries against a target protein antigen, and the identified or selected antibodies are provided.